Arvaya Healthcare share news, announcements and annual reports
BSE: 524723Commercial Services & SuppliesSmall Cap
Arvaya Healthcare Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1995
Last close ₹113.30up ₹2.20 (1.98%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹111.10.
30 Oct: open ₹113.30, high ₹113.30, low ₹113.30
52-week range of traded prices to 30 Oct 2026
₹47.72Low, 3 Nov 2025₹145.00High, 28 Jul 2026
- The board meets on 4 Nov 2026. Every company's board meetings
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹588 Cr2,703rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.17
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 250
Arvaya Healthcare board meetings
125 filed, newest first. Page 1 of 3.
Oct 2026
29 Oct · Board meeting
Meeting on 4 Nov 202619 Oct · Board meeting
Meeting on 24 Oct 2026
Aug 2026
26 Aug · Board meeting
21 Aug · Board meeting
Meeting on 26 Aug 20266 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jul 2026
11 Jul · Board meeting
6 Jul · Board meeting
Meeting on 11 Jul 2026: rights issue of equity shares and preferential issue of shares1 Jul · Board meeting
Meeting on 4 Jul 2026
Jun 2026
May 2026
21 May · Board meeting
Meeting on 28 May 2026: audited results
Mar 2026
17 Mar · Board meeting
13 Mar · Board meeting
Meeting on 17 Mar 2026: increase in authorised capital6 Mar · Board meeting
Meeting on 11 Mar 20262 Mar · Board meeting
Meeting on 4 Mar 2026
Feb 2026
9 Feb · Board meeting
Meeting on 13 Feb 2026: quarterly results6 Feb · Board meeting
Jan 2026
31 Jan · Board meeting
Oct 2025
29 Oct · Board meeting
Meeting on 4 Nov 2025: increase in authorised capital, preferential issue of shares and quarterly results
Sep 2025
19 Sep · Board meeting
Meeting on 26 Sep 2025: voluntary delisting of shares
Jul 2025
21 Jul · Board meeting
Meeting on 28 Jul 2025: quarterly results
May 2025
19 May · Board meeting
Meeting on 26 May 2025: audited results
Mar 2025
Jan 2025
27 Jan · Board meeting
Meeting on 4 Feb 2025: quarterly results7 Jan · Board meeting
2 Jan · Board meeting
Meeting on 7 Jan 2025
Dec 2024
26 Dec · Board meeting
23 Dec · Board meeting
Meeting on 26 Dec 2024: increase in authorised capital and preferential issue of shares